ACT Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-55,500
Closed -$1.04M 74
2026
Q1
$1.04M Hold
55,500
0.82% 18
2025
Q4
$1.28M Buy
+55,500
New +$1.43M 1.04% 21
2022
Q3
$15.7M Sell
222,800
-6,100
-3% -$522K 21.69% 1
2022
Q2
$16.2M Sell
228,900
-9,200
-4% -$593K 22.71% 1
2022
Q1
$19M Sell
238,100
-20,000
-8% -$1.49M 20.13% 1
2021
Q4
$23.6M Sell
258,100
-10,100
-4% -$1.08M 17.04% 1
2021
Q3
$34.5M Buy
268,200
+36,600
+16% +$5.12M 17.87% 1
2021
Q2
$35.3M Buy
+231,600
New +$30.5M 18.15% 1

Other funds holding STAA

ACT Capital Management's STAA Position: Q2 2026 in Review

ACT Capital Management sold out of STAAR Surgical (STAA) in Q2 2026, closing a stake of 55,500 shares — an estimated $1.04M sold.

ACT Capital Management first reported a position in STAA in Q2 2021 and held it in 8 quarters. The position peaked at $35.3M in Q2 2021. 49 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • ACT Capital Management reported no remaining STAAR Surgical position as of Q2 2026 after selling out during the quarter.
  • ACT Capital Management sold 55,500 STAAR Surgical shares in Q2 2026, an estimated $1.04M.
  • ACT Capital Management first reported a position in STAAR Surgical in Q2 2021 and held it in 8 quarters.
  • ACT Capital Management's STAAR Surgical position peaked at $35.3M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.